The innate immune system comprises several classes of pattern recognition receptors, including Toll- like receptors (TLRs), NOD-like receptors (NLRs), and RIG-1-like receptors (RLRs). TLRs recognize microbes on the cell surface and in endosomes, whereas NLRs and RLRs detect microbial components in the cytosol. In some autoinflammatory conditions, abnormalities in NLR signaling pathways are involved in pathogenesis, as exemplified by cryopyrin mutations associated with three autoinflammatory disorders: familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal-onset multiple-system inflammatory disease. Cryopyrin forms a multi-protein complex termed 'the inflammasome', which contains the ASC and caspase-1, and promotes caspase-1 activation and processing of pro-interleukin (IL)-12 into an active form, the secretion of which leads to a potent inflammatory response. Recent studies have demonstrated that cryopyrin mutations found in patients with autoinflammatory disease function as activating mutations resulting in enhanced IL-12 secretion. In addition, pyrin, the product of familial fever (FMF), negatively regulates the cryopyrin inflammasome signaling. Results from our laboratory and others show that cryopyrin and ASC play a critical role in the response of macrophages to microbial components, bacteria and viruses. Altogether, the central hypothesis on which this proposal is based is that dysregulated cryopyrin inflammasome signaling is a primary contributor to the spectrum of autoinflammatory diseases. To address our hypotheses and to understand the role of innate immune responses in inflammatory and infectious diseases, we propose to study the role of cryopyrin/ASC signaling pathway in inflammatory disease, host defense and regulation of cytokine/chemokine secretion. The proposed studies will help development of new molecular insights into the molecular and cellular mechanisms regulating infection and autoinflammation, thus leading to novel therapeutic targets for inflammatory and infectious diseases.
The studies proposed will provide novel insights into the physiological role of the innate immune system/cryopyrin signaling in inflammation, host defense and into the pathogenesis of autoinflammatory syndromes thus leading to novel therapeutic targets for inflammatory and infectious diseases.
| Tartey, Sarang; Gurung, Prajwal; Dasari, Tejasvi Krishna et al. (2018) ASK1/2 signaling promotes inflammation in a mouse model of neutrophilic dermatosis. J Clin Invest 128:2042-2047 |
| Karki, Rajendra; Lee, Ein; Place, David et al. (2018) IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation. Cell 173:920-933.e13 |
| Malireddi, R K Subbarao; Gurung, Prajwal; Mavuluri, Jayadev et al. (2018) TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. J Exp Med 215:1023-1034 |
| Sharma, Deepika; Malik, Ankit; Guy, Clifford S et al. (2018) Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis. Gastroenterology 154:948-964.e8 |
| Malik, Ankit; Kanneganti, Thirumala-Devi (2018) Function and regulation of IL-1? in inflammatory diseases and cancer. Immunol Rev 281:124-137 |
| Place, David E; Kanneganti, Thirumala-Devi (2018) Recent advances in inflammasome biology. Curr Opin Immunol 50:32-38 |
| Zhu, Qifan; Zheng, Min; Balakrishnan, Arjun et al. (2018) Gasdermin D Promotes AIM2 Inflammasome Activation and Is Required for Host Protection against Francisella novicida. J Immunol 201:3662-3668 |
| Kuriakose, Teneema; Kanneganti, Thirumala-Devi (2018) ZBP1: Innate Sensor Regulating Cell Death and Inflammation. Trends Immunol 39:123-134 |
| Kuriakose, Teneema; Kanneganti, Thirumala-Devi (2018) Is Inflammasome a Potential Target of Prophylaxis in Rheumatic Heart Disease? Circulation 138:2662-2665 |
| Zhu, Qifan; Man, Si Ming; Karki, Rajendra et al. (2018) Detrimental Type I Interferon Signaling Dominates Protective AIM2 Inflammasome Responses during Francisella novicida Infection. Cell Rep 22:3168-3174 |
Showing the most recent 10 out of 120 publications
